Best Practice & Research Clinical Haematology
Volume 22, Issue 3 , Pages 395-407, September 2009

Advances in the biology and therapy of patients with chronic myeloid leukaemia

  • Elias Jabbour, MD (Assistant Professor)

      Affiliations

    • Department of Leukemia, The University of Texas, Unit 428, M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 713 792 7305; Fax: +1 713 794 4997.
    • ,
  • Carmen Fava, MD (Professor)

      Affiliations

    • Division of Haematology and Internal Medicine, Department of Biological Sciences of the University of Turin, Turin, Italy
    • ,
  • Hagop Kantarjian, MD (Professor)

      Affiliations

    • Department of Leukemia, The University of Texas, Unit 428, M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(09)00066-8

doi:10.1016/j.beha.2009.09.002

Best Practice & Research Clinical Haematology
Volume 22, Issue 3 , Pages 395-407, September 2009

Article Tools